Cardio Diagnostics (NASDAQ:CDIO – Get Free Report) had its target price dropped by equities research analysts at Benchmark from $4.00 to $1.35 in a report issued on Friday, Benzinga reports. The brokerage presently has a “speculative buy” rating on the stock. Benchmark’s price target would indicate a potential upside of 23.85% from the stock’s current price.
Cardio Diagnostics Stock Up 6.9 %
Cardio Diagnostics stock opened at $1.09 on Friday. Cardio Diagnostics has a 1-year low of $0.17 and a 1-year high of $3.56. The company has a fifty day simple moving average of $1.43 and a 200 day simple moving average of $1.51.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of CDIO. Bank of America Corp DE bought a new position in shares of Cardio Diagnostics in the 1st quarter valued at about $59,000. Geode Capital Management LLC bought a new position in shares of Cardio Diagnostics in the 1st quarter valued at about $290,000. State Street Corp bought a new position in shares of Cardio Diagnostics in the 1st quarter valued at about $163,000. Vontobel Holding Ltd. bought a new position in shares of Cardio Diagnostics in the 4th quarter valued at about $30,000. Finally, Northern Trust Corp bought a new position in shares of Cardio Diagnostics in the 4th quarter valued at about $115,000. Institutional investors own 8.06% of the company’s stock.
Cardio Diagnostics Company Profile
Cardio Diagnostics Holdings, Inc, an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.
Featured Stories
- Five stocks we like better than Cardio Diagnostics
- 3 Warren Buffett Stocks to Buy Now
- Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
- 3 REITs to Buy and Hold for the Long Term
- Comprehensive PepsiCo Stock Analysis
- Where to Find Earnings Call Transcripts
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Receive News & Ratings for Cardio Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardio Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.